GO:0098792 xenophagy: Selective Autophagy of Intracellular Pathogens, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098792 xenophagy is the selective degradation of intracellular pathogens or pathogen components by macroautophagy.
• Xenophagy is a core innate immune defense that restricts bacteria, viruses, and parasites inside host cells.
• The V-ATPase-ATG16L1 axis is a key initiation mechanism for xenophagy, targeted by bacterial effectors.
• Pathogens such as Mycobacterium bovis and Mycobacterium leprae manipulate mitophagy and xenophagy to survive or are cleared by it.
• Xenophagy has emerging roles in cancer immunity and immunotherapy, including intratumoral probiotic approaches.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect xenophagy gene function.
Description
Xenophagy (GO:0098792) is a selective form of macroautophagy dedicated to the capture and lysosomal degradation of intracellular pathogens, including bacteria, viruses, and parasites, or parts of them such as viral capsids. Unlike bulk autophagy, xenophagy uses specific cargo receptors and signaling adaptors to recognize pathogen-associated molecular patterns and damaged pathogen-containing vacuoles, delivering them to autophagosomes for destruction. This process is a central arm of cell-autonomous innate immunity and represents a battlefield between host defense and microbial evasion strategies. Understanding xenophagy is therefore critical for infectious disease research, host-pathogen interaction studies, and the development of new anti-infective and immunotherapeutic strategies. The pathway is also implicated in cancer biology, where it can influence tumor immunity and response to therapy. Researchers study xenophagy using genetic tools such as CRISPR knockout and knock-in models to identify essential genes and regulatory nodes.
xenophagy At A Glance
| GO ID | GO:0098792 |
|---|---|
| GO term | xenophagy |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Selective degradation of intracellular pathogens or pathogen components by macroautophagy |
| Related process | Macroautophagy, innate immunity, host-pathogen interaction |
| Key initiation axis | V-ATPase-ATG16L1 axis |
| Pathogen examples | Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium leprae, viruses |
| Disease relevance | Infectious diseases, cancer immunity |
What Is GO:0098792?
According to the Gene Ontology, GO:0098792 xenophagy is defined as the selective degradation of an intracellular pathogen or some part of an intracellular pathogen (e.g., viral capsid) by macroautophagy. In other words, it is a targeted autophagy process in which the cell recognizes invading microorganisms or their remnants and encapsulates them in double-membrane autophagosomes for delivery to lysosomes, leading to their elimination.
Why Is xenophagy Important in Cell Biology?
Xenophagy is a fundamental host defense mechanism that directly eliminates intracellular pathogens and shapes the outcome of infections. Its dysregulation is linked to pathogen persistence, chronic infection, and inflammatory pathology, as seen in mycobacterial diseases. Moreover, xenophagy intersects with cancer biology and immunotherapy, where it can modulate antitumor immunity. Understanding xenophagy provides insights into conserved innate immune strategies and offers targets for host-directed therapies.
• Provides a cell-autonomous defense against intracellular bacteria, viruses, and parasites.
• Controls mycobacterial infections including M. tuberculosis, M. bovis, and M. leprae.
• Is a target of pathogen evasion mechanisms, revealing host-pathogen co-evolution.
• Plays a role in cancer immunity and may be harnessed for immunotherapy.
• Involves selective cargo receptors and signaling hubs that are potential drug targets.
• Can be studied with CRISPR screens to identify novel regulators.
• Links autophagy machinery to innate immune signaling.
• Has implications for vaccine development and host-directed antimicrobial therapies.
• Contributes to cellular quality control by removing damaged pathogen-containing compartments.
• Emerging evidence suggests roles in inflammatory diseases and tissue homeostasis.
What Happens During xenophagy?
Pathogen Recognition and Cargo Selection
In simple terms: The cell spots invaders and tags them for destruction.
Xenophagy begins when intracellular pathogens or damaged pathogen-containing vacuoles are recognized by host pattern recognition receptors and ubiquitin ligases, leading to ubiquitination of the pathogen surface. Cargo receptors such as p62/SQSTM1, NDP52, and OPTN bind ubiquitinated cargo and recruit LC3-positive autophagosomes. This selective recognition ensures that only pathogens, not bulk cytoplasm, are targeted.
Initiation via the V-ATPase-ATG16L1 Axis
In simple terms: A specific molecular switch starts the autophagy machine around the pathogen.
A key initiation mechanism for xenophagy involves the vacuolar-type H+-ATPase (V-ATPase) on pathogen-containing vacuoles, which recruits ATG16L1 and the autophagy machinery. Bacterial effectors can disrupt this axis to evade xenophagy, highlighting its importance. This step is regulated by upstream signals including AMPK and mTORC1.
Autophagosome Formation and Elongation
In simple terms: A double membrane wraps around the pathogen.
Following initiation, the phagophore expands through the action of ATG proteins, including ATG5-ATG12-ATG16L1 and LC3 lipidation, to engulf the pathogen. The autophagosome membrane seals to form a double-membrane vesicle containing the pathogen.
Lysosomal Fusion and Degradation
In simple terms: The wrapped pathogen is delivered to the cell's recycling center for destruction.
The autophagosome fuses with lysosomes to form autolysosomes, where acidic hydrolases degrade the pathogen. This final step is essential for killing and for generating antigens for immune presentation.
Pathogen Evasion and Manipulation
In simple terms: Some germs fight back by disabling the cell's defense.
Pathogens have evolved strategies to evade xenophagy, such as M. bovis inducing mitophagy to suppress host xenophagy for its survival. Other bacteria secrete effectors that inhibit V-ATPase-ATG16L1 signaling. Understanding these evasion tactics informs host-directed therapies.
Key Genes Involved in GO:0098792 xenophagy
The following genes and proteins are central to xenophagy, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG16L1 | Core autophagy factor recruited by V-ATPase to initiate xenophagy | Target for bacterial evasion; knockout reduces xenophagy |
| V-ATPase | Recruits ATG16L1 to pathogen vacuole | Initiation hub; targeted by effectors |
| LC3 (MAP1LC3B) | Autophagosome membrane marker; binds cargo receptors | Essential for autophagosome formation |
| SQSTM1 (p62) | Cargo receptor recognizing ubiquitinated pathogens | Links ubiquitin signaling to autophagy |
| NDP52 (CALCOCO2) | Cargo receptor for ubiquitinated bacteria | Selective xenophagy of Salmonella |
| OPTN | Cargo receptor involved in xenophagy | Modulates bacterial clearance |
| ATG5 | Essential for LC3 lipidation and autophagosome elongation | Knockout blocks xenophagy |
| ATG7 | E1-like enzyme for ubiquitin-like conjugation | Required for autophagosome formation |
| ATG12 | Conjugates with ATG5 for autophagosome elongation | Core autophagy machinery |
| ULK1 | Initiation kinase regulated by AMPK/mTORC1 | Upstream regulator of xenophagy |
| AMPK | Energy sensor activating autophagy | Promotes xenophagy under stress |
| mTORC1 | Inhibits autophagy under nutrient-rich conditions | Negative regulator of xenophagy |
| TBK1 | Kinase phosphorylating cargo receptors | Enhances xenophagy of bacteria |
| RAB7 | Late endosome/lysosome fusion regulator | Promotes autolysosome formation |
| Mycobacterium bovis | Pathogen that induces mitophagy to suppress xenophagy | Model for evasion |
| Mycobacterium leprae | Target of xenophagy in leprosy reactions | Clinical relevance |
How Is xenophagy Regulated?
Xenophagy is regulated at multiple levels. Upstream, the mTORC1 kinase inhibits autophagy under nutrient-rich conditions, while AMPK activates it during energy stress. The V-ATPase-ATG16L1 axis serves as a pathogen-sensing initiation platform. Cargo receptors such as p62, NDP52, and OPTN are phosphorylated by TBK1 to enhance their affinity for ubiquitinated pathogens. Pathogens can manipulate these pathways; for example, Mycobacterium bovis induces mitophagy to suppress xenophagy. Additionally, inflammatory cytokines and immune signals modulate xenophagy efficiency in infected cells.
xenophagy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATG16L1 | Bacterial evasion, Crohn's disease susceptibility | Knockout intestinal epithelial cells |
| SQSTM1 (p62) | Infectious disease, Paget's disease | Knockout macrophages |
| Mycobacterium bovis | Tuberculosis in cattle and humans | Infection of bovine macrophages |
| Mycobacterium leprae | Leprosy | Human Schwann cell models |
| Probiotic strains | Pancreatic cancer immunotherapy | Intratumoral probiotic administration in mice |
Xenophagy in Infectious Diseases
Xenophagy is critical for controlling intracellular pathogens such as Mycobacterium tuberculosis, M. bovis, and M. leprae. Deficiencies in xenophagy lead to pathogen persistence and chronic infection. In leprosy, xenophagy is associated with elimination of M. leprae during type 1 or type 2 reactions. Bacterial effectors that block xenophagy contribute to virulence.
Xenophagy in Cancer
Xenophagy has context-dependent roles in cancer, influencing tumor immunity and response to immunotherapy. Recent studies show that intratumoral probiotics can activate xenophagy to enhance pancreatic cancer immunotherapy. Thus, xenophagy modulation may be a novel anticancer strategy.
Xenophagy in Innate Immunity
Xenophagy is a cornerstone of innate immunity, acting as a cell-autonomous defense that also shapes adaptive immune responses by generating pathogen-derived antigens. Its interplay with other immune pathways determines infection outcomes.
From xenophagy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate xenophagy initiation? | CRISPR knockout in HeLa or macrophages |
| Does a point mutation in ATG16L1 affect V-ATPase binding? | Knock-in point mutant cell lines |
| Can a tagged cargo receptor be tracked during infection? | Knock-in GFP-LC3 or mCherry-NDP52 |
| Does overexpression of p62 enhance bacterial clearance? | Overexpression stable cell lines |
| Which genes are essential for xenophagy? | Genome-wide CRISPR knockout screen |
| Does a pathogen effector inhibit xenophagy? | Infection with effector-expressing strains |
How to Study the xenophagy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | LC3 puncta, colocalization with pathogens | Visualizing xenophagy in infected cells |
| CRISPR knockout screen | Host genes required for xenophagy | Identifying novel regulators |
| CFU assay | Intracellular bacterial survival | Testing gene function in infection |
| Immunoblotting | LC3 lipidation, p62 degradation | Monitoring autophagy flux |
| Proteomics | Protein interactions in xenophagy | Mapping cargo receptor complexes |
| RNA-seq | Transcriptional changes during infection | Host response profiling |
| Flow cytometry | Pathogen load in single cells | High-throughput screening |
| Live-cell imaging | Dynamics of autophagosome formation | Real-time xenophagy analysis |
Fluorescence Microscopy and Imaging
Confocal microscopy of LC3 puncta and colocalization with pathogens is a standard method to monitor xenophagy. Live-cell imaging can track autophagosome formation and lysosomal fusion.
CRISPR Screens and Genetic Perturbation
Genome-wide CRISPR knockout screens have identified host factors required for xenophagy, such as the V-ATPase-ATG16L1 axis. Targeted knockout and knock-in models validate candidate genes.
Proteomics and Immunoprecipitation
Mass spectrometry-based proteomics can identify cargo receptors and pathogen proteins interacting with autophagy machinery. Immunoprecipitation of ATG16L1 or LC3 followed by mass spectrometry reveals dynamic complexes.
Bacterial Survival Assays
Colony-forming unit (CFU) assays quantify intracellular bacterial survival after xenophagy induction or inhibition. These assays are used to test host gene knockouts and drug treatments.
How CRISPR Can Be Used to Study GO:0098792 xenophagy
Knockout
CRISPR knockout of genes such as ATG16L1, ATG5, or SQSTM1 abolishes xenophagy and increases intracellular pathogen survival, providing causal evidence for their role. Knockout cell lines are essential for dissecting initiation versus execution steps.
Point Mutation
Knock-in of point mutations in ATG16L1 or cargo receptors can disrupt specific interactions, such as V-ATPase binding, without affecting overall protein stability. This allows precise mapping of functional domains.
Knock-in
Tagged knock-in of LC3 or NDP52 with fluorescent proteins enables real-time tracking of autophagosomes and cargo recruitment during infection. Knock-in of reporter genes can also quantify xenophagic flux.
Overexpression
Overexpression of cargo receptors like p62 or OPTN can enhance xenophagy and reduce bacterial burden, demonstrating sufficiency. Conversely, overexpression of pathogen effectors can inhibit xenophagy, revealing evasion mechanisms.
How EDITGENE Supports xenophagy Research
Researchers studying xenophagy-related genes often need to determine whether a candidate gene is causally involved in pathogen clearance or immune regulation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for xenophagy research.
Contact EDITGENE today to design your custom CRISPR model for xenophagy research.
Frequently Asked Questions About xenophagy
What is xenophagy?
Xenophagy is the selective degradation of intracellular pathogens or their components by macroautophagy, a key innate immune defense.
What genes are involved in xenophagy?
Key genes include ATG16L1, ATG5, ATG7, LC3, SQSTM1 (p62), NDP52, OPTN, and TBK1, among others.
What is the V-ATPase-ATG16L1 axis in xenophagy?
It is a mechanism where the V-ATPase on pathogen-containing vacuoles recruits ATG16L1 to initiate xenophagy.
How do pathogens evade xenophagy?
Pathogens can secrete effectors that disrupt the V-ATPase-ATG16L1 axis or induce mitophagy to suppress xenophagy, as seen with Mycobacterium bovis.
Is xenophagy involved in cancer?
Yes, xenophagy can influence tumor immunity and has been linked to immunotherapy responses in pancreatic cancer.
What diseases are associated with defective xenophagy?
Defective xenophagy is associated with mycobacterial infections such as tuberculosis and leprosy, and may contribute to inflammatory diseases.
How can I study xenophagy in the lab?
Common methods include confocal microscopy of LC3 puncta, CFU assays, CRISPR knockout screens, and proteomics.
What is the difference between autophagy and xenophagy?
Autophagy is a general degradation process, while xenophagy is a selective form targeting intracellular pathogens.
Can xenophagy be targeted for therapy?
Yes, host-directed therapies that enhance xenophagy are being explored for infectious diseases and cancer immunotherapy.
What model systems are used to study xenophagy?
Cell lines (HeLa, macrophages), primary cells, and animal models of infection are commonly used, often with CRISPR gene editing.
Conclusion
Xenophagy (GO:0098792) is a specialized autophagic process that serves as a critical defense against intracellular pathogens. Its molecular mechanisms, including the V-ATPase-ATG16L1 axis and cargo receptor signaling, are finely regulated and frequently targeted by pathogens. Beyond infection, xenophagy is emerging as a modulator of cancer immunity and a potential therapeutic target. Continued research using CRISPR-based models will unravel new regulators and translational opportunities.
References
- 1. Ammanathan V et al.. 2020. Xenophagy in cancer.. Semin Cancer Biol 66:163-170 PMID: 32126260
- 2. Wang Z et al.. 2020. Xenophagy in innate immunity: A battle between host and pathogen.. Dev Comp Immunol 109:103693 PMID: 32243873
- 3. Xu Y et al.. 2019. A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy.. Cell 178(3):552-566.e20 PMID: 31327526
- 4. Song Y et al.. 2022. Mycobacterium bovis induces mitophagy to suppress host xenophagy for its intracellular survival.. Autophagy 18(6):1401-1415 PMID: 34720021
- 5. Pao KC et al.. 2019. Tug of War in the Xenophagy World.. Trends Cell Biol 29(10):767-769 PMID: 31471010
- 6. Zhao X et al.. 2022. Editorial: Xenophagy: Its role in pathogen infections.. Front Cell Infect Microbiol 12:1003451 PMID: 36093208
- 7. Cerqueira DDN et al.. 2023. Xenophagy as a Strategy for Mycobacterium leprae Elimination during Type 1 or Type 2 Leprosy Reactions: A Systematic Review.. Pathogens 12(12) PMID: 38133338
- 8. Li B et al.. 2026. Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy.. Cell Host Microbe 34(4):657-671.e7 PMID: 41794037
